Glenmark Pharmaceuticals Opens Allentown Distribution Hub
The pharmaceutical company has consolidated its U.S. shipping operations into a new 160,000-square-foot facility in Allentown.
Updated on Oct. 30, 2026 in Healthcare
Live Poll
Does increased domestic pharmaceutical infrastructure improve medicine supply reliability for patients?
Glenmark Pharmaceuticals has launched a new distribution hub in Allentown to centralize its national shipping operations. The 6.5-acre facility manages the distribution of over 200 FDA-authorized products across the country.
Why it matters
The company selected the Lehigh Valley for its new hub due to the available workforce and its strategic proximity to both customers and corporate leadership. This move centralizes the company's logistical footprint to improve the efficiency of delivering millions of prescription units nationwide.
The new 160,000-square-foot Allentown hub manages 229 FDA-authorized products for distribution to 321 locations across 43 states. Since its opening, the facility has processed over 61 million units.
The players
Glenmark Pharmaceuticals
This global pharmaceutical company manages a diverse portfolio of FDA-authorized products and has invested nearly $1 billion into its U.S. infrastructure.
The details
The Allentown site features specialized infrastructure, including cold-chain refrigerated storage, controlled-room-temperature sections, and DEA-compliant vaults for secure product handling. A team of 45 staff members oversees all administration, quality control, and shipping activities at the location.
Timeline
As of October 30, 2026, the distribution hub is fully operational.
Market Landscape
The opening of this Allentown facility follows the pharmaceutical industry's broader shift toward centralized logistics to meet stringent cold-chain storage requirements. This consolidation allows Glenmark to optimize its delivery routes and improve supply chain stability against larger industry competitors.
The centralization of these shipping operations aims to improve the efficiency and reliability of pharmaceutical product delivery for patients across 43 states. Local residents and stakeholders may see increased logistical activity in the Lehigh Valley as the hub manages its national distribution volume.
The takeaway
Centralizing logistics into specialized hubs allows pharmaceutical companies to better manage complex requirements like temperature control and DEA compliance. Improving supply chain infrastructure is a critical step for maintaining consistent access to essential medications for patients nationwide.
Further reading
For more information on the regional medical sector, visit the Allentown healthcare section.
Live Poll
Does increased domestic pharmaceutical infrastructure improve medicine supply reliability for patients?
